Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic Prediction of Keratoplasty in Fuchs Endothelial Corneal Dystrophy.

Ophthalmology·2026

Same author

Real Architecture for 3D Tissue (RAFT): Mechanical Properties and Ability to Support the 3D Culture of Porcine Corneal Endothelial Cells.

Journal of biomedical materials research. Part A·2026

Same author

Influence of inflammatory and metabolic factors on keratoconus risk: a causal inference analysis.

Eye (London, England)·2026

Same author

Exploring the histopathological signature of repeat-mediated Fuchs endothelial corneal dystrophy.

Acta ophthalmologica·2025

Same author

Rare variants in MIR184 are a novel genetic cause of Fuchs endothelial corneal dystrophy.

Genetics in medicine : official journal of the American College of Medical Genetics·2025

Same author

Decoding the Cornea-Glaucoma Association: Evidence From Mendelian Randomization.

Investigative ophthalmology & visual science·2025

Search research articles

Related Experiment Video

Updated: May 29, 2026

Isolation and Identification of Limbal Niche Cells

Isolation and Identification of Limbal Niche Cells

Published on: October 27, 2023

Corneal stem cells in the eye clinic.

Alex J Shortt¹, Stephen J Tuft, Julie T Daniels

¹Department of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK. a.shortt@ucl.ac.uk

British Medical Bulletin

|September 20, 2011

Summary

Corneal epithelial stem cell (SC) deficiency causes blindness. Both corneal transplantation and ex vivo SC expansion show similar outcomes, but cell expansion offers a safer donor eye approach.

Area of Science:

Ophthalmology
Regenerative Medicine
Cell Therapy

Background:

Corneal opacity is a leading cause of blindness worldwide.
It often results from infection or trauma leading to scarring.
Stem cell deficiency impairs corneal surface maintenance.

Purpose of the Study:

To review treatments for corneal epithelial stem cell deficiency.
To compare the efficacy and risks of current therapeutic approaches.

Main Methods:

Systematic review of clinical studies.
Inclusion of individual case series on corneal epithelial stem cell deficiency treatments.

Main Results:

Two primary treatments: corneal transplantation and ex vivo stem cell expansion.

More Related Videos

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Published on: October 24, 2018

Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration

Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration

Published on: September 12, 2014

Related Experiment Videos

Last Updated: May 29, 2026

Isolation and Identification of Limbal Niche Cells

Isolation and Identification of Limbal Niche Cells

Published on: October 27, 2023

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Published on: October 24, 2018

Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration

Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration

Published on: September 12, 2014

Both methods demonstrate comparable clinical outcomes.

Ex vivo expansion involves a smaller biopsy, reducing donor eye risk.

Conclusions:

Treatment algorithms for stem cell failure are evolving.
Further research is needed to clarify the proportion of true stem cells in cultures and their long-term survival.
Future research includes tissue engineering, gene therapy for hereditary disorders, and broader cell therapy applications in ophthalmology.